St. Jude Medical, Inc. , a global medical device company, today announced approval from the U.S. Food and Drug Administration for the Allure Quadra™ Cardiac Resynchronization Therapy Pacemaker , which provides additional pacing innovations for physicians to treat patients with heart failure.
from Content Keyword RSS http://ift.tt/1hlCaV5
via IFTTT
from Content Keyword RSS http://ift.tt/1hlCaV5
via IFTTT
No comments:
Post a Comment